.png)
Natco Pharma Limited based in Hyderabad has today declared the release of Everolimus tablets 1mg, the generic of Zortress made by Novartis, within the imunosuppressant group. Product will be available in the U.S. market immediately via its...
Medanta, one of India’s leading super-specialty healthcare providers, has taken a major step in advancing eye care with the launch of the UNITY Vitreoretinal Cataract System (VCS) at Medanta Mediclinic, Defence Colony, New Delhi...
Philips has revealed an enhancement of its partnership with Nicolab, a prominent AI-based stroke management company, to improve stroke diagnosis and treatment in India. This partnership signifies a noteworthy step towards addressing one...
In a significant development aimed at bolstering India's medical technology (MedTech) sector, the Anusandhan National Research Foundation (ANRF), in conjunction with the Indian Council of Medical Research (ICMR) and the Gates Foundation...
Recently published data from the FLUNITY-HD Study in The Lancet illustrates that Efluelda provided significantly more protection against hospitalizations than standard-dose influenza vaccines in adults aged 65 and older...
Indegene today unveiled its ambitious expansion of the Consulting Practice, reaffirming its ongoing commitment to enable life sciences organizations to navigate value and risk in large transformation efforts, in a complex, technology-driven world...
In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Ankit Gupta, President of ASPA, discusses how serialization and digital authentication are driving a paradigm shift in the pharmaceutical industry
Biocon Biologics Ltd. (BBL), a leading global biosimilars company and subsidiary of Biocon Ltd., announced today the extension of its strategic collaboration with Civica, Inc. to include a new medicines, Insulin Glargine, to improve patient access...
India’s biotech and pharmaceutical R&D journey began much earlier than many believe, with its foundations laid in the 1990s and early 2000s. Indian companies, inspired by global multinationals such as Pfizer, Merck, and Novartis, invested heavily in
Tamil Nadu is under the spotlight after a spate of child deaths linked to adulterated cough syrup manufactured by Sresan Pharmaceuticals. The deaths have now increased to 23, as two more children, Garvik Pawar, and Mayank Suryawanshi
.jpg)
.jpg)
, CDSCO.jpg)